Japan: Implementing a DX Platform for Increasing Success Rates and Reducing Time to Market in Pharma R&D

*This webinar will be presented in Japanese.

Digital transformation (DX) and AI/LLM application have the potential to dramatically change the way pharmaceutical organizations conduct R&D. Transforming the data culture of the organization and implementing an appropriate data strategy is key to enabling the utilization of diverse and complex R&D data across multiple groups – ultimately improving success rates and reducing time to market.

Discover how Genedata facilitates the use of research and clinical data for improving the quality, safety and efficacy of drug candidates. The webinar will showcase customer use cases and introduce how researchers are utilizing data at each step of the R&D workflow in order to improve their decision making.